When COVID-19 first appeared, it coincided with the high seasonal influenza activity in China; during this period, over 40% of confirmed COVID-19 cases tested positive for serum IgM against influenza A virus and 7.5% positive against influenza B (Yue et al. 2020; Cheng et al. 2021). This evidence concerns the gene CD40LG and COVID-19.